Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 04.02.2019 2 Am J Gastroenterol 2 Dig Dis Sci 1 Endoscopy 1 Eur J Pediatr 2 Eur Radiol 4 Gastroenterology 1 Gut 15 Hepatology 3 Int J Cancer 1 J Gastroenterol 1 J Gastroenterol Hepatol 8 J Hepatol 1 Oncogene 1 PLoS Med 7 PLoS One 1 Radiology 1 Transplant Proc 4 Transplantation

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. FENG Z, Marrero JA, Khaderi S, Singal AG, et al
   Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.
   Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000068.
   PubMed     Text format     Abstract available
   
   
2. BAJAJ JS, Tandon P, O'Leary JG, Wong F, et al
   Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis.
   Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000044.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

3. NEVENS F, Bittencourt PL, Coenraad MJ, Ding H, et al
   Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
   Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-018-5448.
   PubMed     Text format     Abstract available
   
   
4. LAI LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, et al
   Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.
   Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-019-5477.
   PubMed     Text format     Abstract available
   
   

   
   Endoscopy

5. DHIR V, Adler DG, Pausawasdi N, Maydeo A, et al
   Feasibility of a complete pancreatobiliary linear endoscopic ultrasound examination from the stomach.
   Endoscopy. 2018;50:22-32.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Pediatr

6. LOPEZ-GUTIERREZ JC
   Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
   Eur J Pediatr. 2018 Nov 12. pii: 10.1007/s00431-018-3290.
   PubMed     Text format     Abstract available
   
   

   
   Eur Radiol

7. KIM SS, Hwang JA, Shin HC, Choi SY, et al
   LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
   Eur Radiol. 2019;29:186-194.
   PubMed     Text format     Abstract available
   
   
8. FENG ST, Jia Y, Liao B, Huang B, et al
   Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
   Eur Radiol. 2019 Jan 28. pii: 10.1007/s00330-018-5935.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

9. GRINDHEIM JM, Nicetto D, Donahue G, Zaret KS, et al
   PRC2 proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Gene Expression at Promoter Regions in Euchromatin in Mice.
   Gastroenterology. 2019 Jan 25. pii: S0016-5085(19)30104.
   PubMed     Text format     Abstract available
   
   
10. KO S, Russell JO, Tian J, Gao C, et al
    Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.
    Gastroenterology. 2019;156:187-202.
    PubMed     Text format     Abstract available
    
    
11. MONTANO-LOZA AJ, Hansen BE, Corpechot C, Roccarina D, et al
    Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
    Gastroenterology. 2018 Oct 5. pii: S0016-5085(18)35089.
    PubMed     Text format     Abstract available
    
    
12. PEERY AF, Crockett SD, Murphy CC, Lund JL, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35147.
    PubMed     Text format     Abstract available
    
    

    
    Gut

13. YUAN L, Jiang J, Liu X, Zhang Y, et al
    HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation.
    Gut. 2019 Jan 30. pii: gutjnl-2018-316091. doi: 10.1136/gutjnl-2018-316091.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

14. BAI L, Chen MM, Chen ZD, Zhang P, et al
    FBXW5 mediates the ubiquitination of ASK1 and exacerbates nonalcoholic steatohepatitis.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30537.
    PubMed     Text format     Abstract available
    
    
15. KIM D, Brocker CN, Takahashi S, Yagai T, et al
    Keratin 23 is a PPARA-dependent, MYC-amplified oncogene that promotes hepatocyte proliferation.
    Hepatology. 2019 Jan 29. doi: 10.1002/hep.30530.
    PubMed     Text format     Abstract available
    
    
16. RUSSO N, Brown RS Jr, Shah SL, Krisko TI, et al
    Hepatology Highlights.
    Hepatology. 2019;69:469-472.
    PubMed     Text format    
    
    
17. ZEUZEM S, Bourgeois S, Greenbloom S, Buti M, et al
    JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-infected Patients without Cirrhosis: OMEGA-1.
    Hepatology. 2019 Jan 28. doi: 10.1002/hep.30527.
    PubMed     Text format     Abstract available
    
    
18. PORTA C, Broglia C, Negri F
    Medical treatment of advanced hepatocellular carcinoma patients: the issue is not the right drug, but the right patient.
    Hepatology. 2019 Jan 25. doi: 10.1002/hep.30521.
    PubMed     Text format     Abstract available
    
    
19. WONG GL, Liang LY, Kwok R, Hui AJ, et al
    Low risk of variceal bleeding in cirrhotic patients after variceal screening stratified by liver/spleen stiffness.
    Hepatology. 2019 Jan 25. doi: 10.1002/hep.30522.
    PubMed     Text format     Abstract available
    
    
20. TAPPER EB
    Predicting Overt Hepatic Encephalopathy for the Population with Cirrhosis.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30533.
    PubMed     Text format     Abstract available
    
    
21. SHALIMAR, Sheikh MF, Mookerjee RP, Agarwal B, et al
    Prognostic Role of Ammonia in Cirrhotic Patients.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30534.
    PubMed     Text format     Abstract available
    
    
22. LUDVIGSSON JF, Marschall HU, Hagstrom H, Hoijer J, et al
    Pregnancy outcome in women undergoing liver biopsy during pregnancy: A nationwide population-based cohort study.
    Hepatology. 2018;68:625-633.
    PubMed     Text format     Abstract available
    
    
23. WANGENSTEEN KJ, Wang YJ, Dou Z, Wang AW, et al
    Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
    Hepatology. 2018;68:663-676.
    PubMed     Text format     Abstract available
    
    
24. CAUSSY C, Reeder SB, Sirlin CB, Loomba R, et al
    Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.
    Hepatology. 2018;68:763-772.
    PubMed     Text format     Abstract available
    
    
25. DUAN JL, Ruan B, Yan XC, Liang L, et al
    Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice.
    Hepatology. 2018;68:677-690.
    PubMed     Text format     Abstract available
    
    
26. ZAMORA-VALDES D, Watt KD, Kellogg TA, Poterucha JJ, et al
    Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29848.
    PubMed     Text format     Abstract available
    
    
27. MOEST W, van der Deure W, Koster T, Spee-Dropkova M, et al
    Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas.
    Hepatology. 2018;68:780-782.
    PubMed     Text format    
    
    
28. HUANG R, Gao ZH, Tang A, Sebastiani G, et al
    Transient elastography is an unreliable marker of liver fibrosis in patients with portal vein thrombosis.
    Hepatology. 2018;68:783-785.
    PubMed     Text format    
    
    

    
    Int J Cancer

29. OH E, Kim YJ, An H, Sung D, et al
    Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
    Int J Cancer. 2018 May 9. doi: 10.1002/ijc.31585.
    PubMed     Text format     Abstract available
    
    
30. ABDUL-WAHID A, Cydzik M, Fischer NW, Prodeus A, et al
    Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.
    Int J Cancer. 2018;143:1963-1977.
    PubMed     Text format     Abstract available
    
    
31. MA X, Tan YT, Yang Y, Gao J, et al
    Pre-diagnostic urinary 15-F2t -isoprostane level and liver cancer risk: Results from the Shanghai Women's and Men's Health Studies.
    Int J Cancer. 2018;143:1896-1903.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol

32. OBA A, Kudo A, Akahoshi K, Kishino M, et al
    A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors.
    J Gastroenterol. 2017 May 9. doi: 10.1007/s00535-017-1349.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

33. LAI-HUNG WONG G, Sung JJ
    The emerging role of big data in gastroenterology and hepatology.
    J Gastroenterol Hepatol. 2019;34:307-308.
    PubMed     Text format    
    
    

    
    J Hepatol

34. HUO TI, Liu PH, Hsu CY
    Predicting post-resection recurrence of hepatocellular carcinoma: Spleen stiffness vs. ALBI grade.
    J Hepatol. 2019 Jan 21. pii: S0168-8278(18)32571.
    PubMed     Text format    
    
    
35. WEI W, Li L, Kong G, Zheng Z, et al
    Spleen in hepatocellular carcinoma: More complexity and importance than we knew.
    J Hepatol. 2019 Jan 22. pii: S0168-8278(18)32573.
    PubMed     Text format    
    
    
36. MARINO Z, Darnell A, Lens S, Sapena V, et al
    Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: relevance of non-characterized nodules.
    J Hepatol. 2019 Jan 23. pii: S0168-8278(19)30015.
    PubMed     Text format     Abstract available
    
    
37. XIANG X, Wang Y, Mo DC, Wang SQ, et al
    Liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection: A comment for moving forward.
    J Hepatol. 2019 Jan 23. pii: S0168-8278(18)32572.
    PubMed     Text format    
    
    
38. SINGH V, Singh A, Agarwal R
    Midodrine and albumin in decompensated cirrhosis: Down but not out....
    J Hepatol. 2019 Jan 23. pii: S0168-8278(18)32540.
    PubMed     Text format    
    
    
39. VAN DER MERWE S, Laleman W, Langouche L, Meersseman P, et al
    Reply to: "Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF".
    J Hepatol. 2019 Jan 23. pii: S0168-8278(19)30007.
    PubMed     Text format    
    
    
40. FERRARESE A, Feltracco P, Barbieri S, Cillo U, et al
    Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF.
    J Hepatol. 2019 Jan 23. pii: S0168-8278(18)32389.
    PubMed     Text format    
    
    
41. KESSLER SM, Hoppstadter J, Hosseini K, Laggai S, et al
    Lack of Kupffer cell depletion in diethylnitrosamine-induced hepatic inflammation.
    J Hepatol. 2019 Jan 24. pii: S0168-8278(18)32569.
    PubMed     Text format    
    
    

    
    Oncogene

42. FANG S, Liu M, Li L, Zhang FF, et al
    Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway.
    Oncogene. 2019 Jan 29. pii: 10.1038/s41388-019-0704.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

43. KUMARENDRAN B, O'Reilly MW, Manolopoulos KN, Toulis KA, et al
    Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
    PLoS Med. 2018;15:e1002542.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

44. FINKELMEIER F, Canli O, Peiffer KH, Walter D, et al
    Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
    PLoS One. 2018;13:e0200855.
    PubMed     Text format     Abstract available
    
    
45. ZHENG J, Sadot E, Vigidal JA, Klimstra DS, et al
    Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
    PLoS One. 2018;13:e0200776.
    PubMed     Text format     Abstract available
    
    
46. KIM SE, Park JW, Kim MJ, Jang B, et al
    Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis.
    PLoS One. 2018;13:e0201744.
    PubMed     Text format     Abstract available
    
    
47. CHEN J
    The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
    PLoS One. 2018;13:e0200909.
    PubMed     Text format     Abstract available
    
    
48. COZZI L, Comito T, Fogliata A, Franzese C, et al
    Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma.
    PLoS One. 2018;13:e0201992.
    PubMed     Text format     Abstract available
    
    
49. VANGOITSENHOVEN R, van der Ende M, Corbeels K, Monteiro Carvalho Mori Cunha JP, et al
    At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice.
    PLoS One. 2018;13:e0200779.
    PubMed     Text format     Abstract available
    
    
50. PIASECKI P, Narloch J, Brzozowski K, Ziecina P, et al
    The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
    PLoS One. 2018;13:e0200488.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

51. KIM YY, Kim MJ, Kim EH, Roh YH, et al
    Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018.
    Radiology. 2019 Jan 29:181995. doi: 10.1148/radiol.2019181995.
    PubMed     Text format     Abstract available
    
    

    
    Transplant Proc

52. FEBRERO B, Ramirez P, Martinez-Alarcon L, Abete C, et al
    Group Psychotherapy Could Improve Depression in Cirrhotic Patients on the Liver Transplant Waiting List.
    Transplant Proc. 2018 Jun 28. pii: S0041-1345(18)30833.
    PubMed     Text format     Abstract available
    
    

    
    Transplantation

53. GIRETTI G, Barbier L, Bucur P, Marques F, et al
    Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation.
    Transplantation. 2018 Jan 2. doi: 10.1097/TP.0000000000002069.
    PubMed     Text format     Abstract available
    
    
54. ADELMANN D, Olmos A, Liu LL, Feiner JR, et al
    Intraoperative management of liver transplant patients without the routine use of renal replacement therapy.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002137.
    PubMed     Text format     Abstract available
    
    
55. CHARLTON M, Levitsky J, Aqel B, O'Grady J, et al
    International Liver Transplant Society Consensus Statement on IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002147.
    PubMed     Text format    
    
    
56. MARCON F, Schlegel A, Bartlett DC, Kalisvaart M, et al
    Utilization of Declined Liver Grafts Yields Comparable Transplant Outcomes and Previous Decline Should Not Be a Deterrent to Graft Use.
    Transplantation. 2018;102:e211-e218.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: